Metrics

From
Developing Potential Drugs for COVID-19 Using Ligand Based Virtual Screening by Kagia Richard American Journal of Pharmacological Sciences. 2020, 8(1), 9-13 doi:10.12691/ajps-8-1-3
Views
8195
Html 7929
Abstract 266
12 May 2020 (publication date) through 17 June 2026 *
18.95 % of article views led to PDF downloads *
*Although we update our data on a daily basis, there may be a 48-hour delay before the most recent numbers are available.
Downloads: 5917
PDF1553
Epub1294
XML1284
PPT0
Figures1341
Tables445
Export: 3781
RIS1159
BibTex1433
Endnote1189
RIS, BibTex, EndNote allows users to search, retrieve and store citations from bibliographic databases such as ABI Inform, the Web of Science, Anthropological Literature, the MLA bibliography, or the catalogs of individual libraries.
Area Chart Example: If your want to see the details of daily statistics for this article, please click here to login our Manuscript Tracking System.
Citations
0
Found additional citations for the article? Please contact us at submission@sciepub.com.
Shares & bookmarks
Facebook0
Twitter0
LinkedIn0
Google +0
Found additional shares or bookmarks for the article? Please contact us at submission@sciepub.com